Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial.

MLA

Marso, Steven P., et al. “Design of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial.” American Heart Journal, vol. 166, no. 5, Nov. 2013, p. 823. EBSCOhost, https://doi.org/10.1016/j.ahj.2013.07.012.

APA

Marso, S. P., Poulter, N. R., Nissen, S. E., Nauck, M. A., Zinman, B., Daniels, G. H., Pocock, S., Steinberg, W. M., Bergenstal, R. M., Mann, J. F. E., Ravn, L. S., Frandsen, K. B., Moses, A. C., & Buse, J. B. (2013). Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. American Heart Journal, 166(5), 823. https://doi.org/10.1016/j.ahj.2013.07.012

Chicago

Marso, Steven P, Neil R Poulter, Steven E Nissen, Michael A Nauck, Bernard Zinman, Gilbert H Daniels, Stuart Pocock, et al. 2013. “Design of the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) Trial.” American Heart Journal 166 (5): 823. doi:10.1016/j.ahj.2013.07.012.